Seattle residents look abroad for psilocybin healing as therapy demand grows and Washington limits supervised use

Psilocybin retreats are drawing Seattle residents seeking psychedelic healing that is framed as therapy rather than tourism. Axios reports that one Seattle-area therapist, Gwen Ingram-Jones, has led retreats at MycoMeditations in Jamaica for three years, typically running eight days and combining group therapy, one-on-one sessions, specialized coaching, and three days of dosing. The piece links retreat interest to a broader mental health shift, citing research including work from the University of Washington on psychedelic therapy for depression, anxiety, and trauma. It also explains the policy backdrop: Washington has not authorized licensed supervised psilocybin settings, even as it runs a University of Washington pilot for veterans and first responders and considers broader legislation. A featured participant, Curt Angell, describes grief and grief-related emotional barriers and says retreats produced spiritual experiences and help releasing grief that he could not access through traditional therapy alone. Costs vary widely, with eight-day trips in Jamaica starting around $6,500.